Suppr超能文献

每月给予地诺单抗成功控制骨巨细胞瘤的多发肺转移:一例报告

The successful control of multiple pulmonary metastasis from giant cell tumor of bone by monthly denosumab administration: A case report.

作者信息

Liu Yang, Liu Meng, Ye Zhaoming, Li Hengyuan

机构信息

Department of Orthopedic Surgery, The Second Affiliated Hospital of Zhejiang University School of Medicine (SAHZU), Hangzhou, Zhejiang, China.

Orthopedics Research Institute of Zhejiang University, Hangzhou, Zhejiang, China.

出版信息

Heliyon. 2024 Aug 25;10(17):e36849. doi: 10.1016/j.heliyon.2024.e36849. eCollection 2024 Sep 15.

Abstract

Giant cell tumor of bone (GCTB) is a locally aggressive benign neoplasm that is associated with a large biological spectrum ranging from latent benign to highly recurrent and occasionally metastatic tumor. In this article, we present a case of a 37-year-old woman who presented with fracture at the distal femur due to GCTB. Bone segment resection and reconstruction were done, and histopathology showed tumor features for GCTB. Later, multiple lung metastasis was found 22 months post-operation, which was verified by biopsy. Then systemic denosumab therapy with different intervals (1-month and 2-month) was tried as the treatment. It was clarified that monthly denosumab administration, instead of 2-month interval, was required to control the progression of the unresectable multiple lung metastasis from GCTB, which could be a choice for the future treatment of these patients.

摘要

骨巨细胞瘤(GCTB)是一种局部侵袭性良性肿瘤,其生物学行为谱广泛,从潜在良性到高度复发甚至偶尔发生转移。在本文中,我们报告了一例37岁女性因骨巨细胞瘤导致股骨远端骨折的病例。进行了骨段切除和重建,组织病理学显示为骨巨细胞瘤的肿瘤特征。术后22个月发现多发肺转移,经活检证实。随后尝试采用不同间隔时间(1个月和2个月)的地诺单抗全身治疗。结果表明,对于控制骨巨细胞瘤不可切除的多发肺转移进展,需要每月给予地诺单抗,而非2个月的间隔时间,这可能是未来这些患者治疗的一种选择。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e5f/11402124/4880cb51e0f2/gr1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验